Q-omics provides the consensus-scored MIR8064 profile across patient tissues and cancer cell-line models. MIR8064 expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in DLBC. Among the 18 cancer types available for tumor–normal comparison, MIR8064 is differentially expressed in 4, with the highest sampling consensus in KIRC. Additionally, MIR8064 RNA expression shows 8,227 significant gene co-expression associations, with the highest sampling consensus in DLBC. Together, these results highlight DLBC, and KIRC as cancer lineages where MIR8064 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR8064 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR8064 survival associations across molecular data types. MIR8064 RNA expression shows survival associations in the most cancer types (14). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR8064 RNA expression–survival associations across cancer types. High MIR8064 expression shows unfavorable associations in DLBC, PAAD, UCEC, KICH, READ and LGG. The DLBC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify DLBC as the clearest survival context for MIR8064 RNA expression.
This table summarizes MIR8064 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for MIR8064. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR8064 shows lower tumor expression in KIRC and THCA and higher tumor expression in LUAD and LIHC. The KIRC box plot shows higher MIR8064 RNA expression in normal versus tumor tissue (log2 FC = −0.131, t-test p = .021).
This table shows molecular features associated with MIR8064 in patient tissues and cancer cell lines. In patient samples, MIR8064 shows the broadest associations at the RNA and protein expression levels, with DLBC recurring as the lineage with the largest associated feature set.
